Blair CS, Beymer MR, Kofron RM, Bolan RK, Jordan WC, Haubrich RH, Wohl AR, Landovitz RJ. PrEP Nonadherence,
White Coat Dosing, and HIV Risk Among a Cohort of MSM.
Open Forum Infect Dis 2020;
7:ofaa329. [PMID:
32851110 PMCID:
PMC7442274 DOI:
10.1093/ofid/ofaa329]
[Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2020] [Accepted: 07/28/2020] [Indexed: 11/13/2022] Open
Abstract
Among a cohort of men who have sex with men in a pre-exposure prophylaxis (PrEP) adherence trial, syphilis requiring treatment was associated with white coat dosing (increased PrEP adherence immediately preceding study visits) when compared with participants with optimal drug concentrations. The findings highlight the need for identifying and reducing barriers to PrEP adherence.
Collapse